Pharmacology
- xxx
Adverse Effects
- Acute/Chronic Hypoventilation (see Acute Hypoventilation, [[Acute Hypoventilation]] and Chronic Hypoventilation, [[Chronic Hypoventilation]])
- Thrombotic Thrombocytopenic Purpura (TTP) (see Thrombotic Thrombocytopenic Purpura, [[Thrombotic Thrombocytopenic Purpura]]): few cases have been reported associated with illicit IV injection of oral Opana ER formulation
References
- CDC Health Advisory, Distributed via Health Alert Network; October 26, 2012, 18:00 ET (6:00 PM ET) CDCHAN-00331-2012-26-10-UPD-N